Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy

T. Welte (Magdeburg, Germany)

Source: Annual Congress 2004 - Community acquired pneumonia
Session: Community acquired pneumonia
Session type: Thematic Poster Session
Number: 1191
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Welte (Magdeburg, Germany). Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy. Eur Respir J 2004; 24: Suppl. 48, 1191

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral combination therapy bosentan/sildenafil delays time to clinical worsening in comparison to bosentan monotherapy
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008


Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006

Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006

A clinical and outcomes assessment of the management of community-acquired pneumonia (CAP): a multinational, prospective, double-blind comparison of moxifloxacin to standard first-line oral monotherapy or combination regimen
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001

Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011

Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001

The clinical value of initial microbiological studies in exacerbations of COPD is questionable and not affected by antibiotics prior to hospitalization
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Comparison of initial drug treatment of incident COPD patients with German treatment guidelines
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020
Year: 2021



Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Clinical management improves the treatment outcome of MDR-TB patients
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017

Incidence of hearing impairment after intra muscular streptomycin of pediatric patients during directly observed treatment short-course using quadruple regimen at a tertiary hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003

The efficacy of an early supported discharge programme for patients admitted to hospital with an exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 593s
Year: 2002

Practical treatment of community acquired pneumonia (CAP) with outpatient parenteral antibiotic therapy (OPAT) and switch therapy: CTRX and LVFX
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008


Duration of therapy in hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007


A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004